Start-Ups Swimming ...
Health Care: Drugs
Auxilium Pharmaceuticals Inc. (AUXL: NASDAQ)
$15.50 0.24 | 1.54%
05/24/13 - 09:40 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 15.26 |
| 52 Week High | 29.37 |
| 52 Week Low | 13.87 |
| Avg. Daily Vol. (Mil) | 0.79 |
| Beta (3 year) | 0.94 |
| Share Related Items | |
| Mkt Cap (Mil) | 752.41 |
| Shares Out (Mil) | 49.31 |
| Float (Mil) | 49.12 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.50 |
| Current Ratio | 5.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 9.50 |
| Price/Sales | 1.94 |
| Price/Book | 3.24 |
| Price/Cash Flow | 7.50 |
| Per Share Data | |
| Earnings | 1.61 |
| Sales | 7.87 |
| Book Value | 4.70 |
| Cash Flow | 2.03 |
| Business Summary | |
|---|---|
| Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company, which develops and markets products to urologists, endocrinologists, orthopedists and select primary care physicians and plastic surgeons who focus on the hand, and rheumatologists. | |
| General Information | |
| 40 Valley Stream Parkway
Malvern, PA 19355 |
|
| www.auxilium.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 526 | |
| CEO: Mr. Adrian Adams | |
| Short Interest | |
| Current Month (Mil) | 5.23 |
| Previous Month (Mil) | 5.03 |
| Short Interest Ratio (Days) | 6.00 |
| Management Effectiveness | |
| Return on Equity | 34.30 |
| Return on Assets | 12.40 |
| Return on Investments | 34.30 |
| Profitability | |
| Gross Margin | 85.50 |
| EBIT Margin | 21.30 |
| Profit Margin | 20.50 |
Portfolios with AUXL
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 23
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 17
- ContributorStocks Rising On Unusual Vo...
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Userinsider buying
Latest AUXL Headlines from TheStreet
- RSI Alert For Auxilium Pharmaceuticals (AUXL) 04.29.13 | 01:04 pm
- Auxilium CEO Goes Against Type, Buying Instead of Selling 04.29.13 | 08:04 am
- Stock Futures Fueled by Anticipated Stimulus 04.29.13 | 07:04 am
- Repros CEO: My Testosterone Drug Helped Gay Cubans Have Lots of Sex 03.28.13 | 12:03 pm
- Auxilium Pharmaceuticals Inc. Stock Upgraded (AUXL) 03.22.13 | 05:03 am
- Insider Buying at Auxilium, Aveo Hints At Big Moves in 2013 12.20.12 | 07:12 am
- 4 More Stocks Jumping on Unusual Volume 12.17.12 | 03:12 pm
- Stocks Under $5: Discount Drug Name
11.29.12 | 06:11 am - Auxilium Pharmaceuticals Inc. Stock Downgraded (AUXL) 11.09.12 | 04:11 am
- Stocks Under $10: Stealth Drug Play 08.29.12 | 06:08 am
Press Releases for AUXL
- Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data From XIAFLEX® (CCH) Frozen Shoulder Syndrome Phase IIa Study - PR Newswire 03.25.13 | 07:03 am
- Auxilium Pharmaceuticals, Inc. To Present At The Cowen And Company 33rd Annual Healthcare Conference - PR Newswire 03.04.13 | 07:03 am
- Auxilium Pharmaceuticals, Inc. To Present At The Leerink Swann Global Healthcare Conference - PR Newswire 02.12.13 | 07:02 am
- Auxilium Pharmaceuticals, Inc. Announces IMPRESS Trials Of XIALFEX® In Peyronie's Disease Were Published Online In The Journal Of Urology - PR Newswire 02.01.13 | 04:02 pm
- Auxilium Pharmaceuticals, Inc. Announces Issuance Of $350.0 Million Of 1.50% Convertible Senior Notes Due 2018 - PR Newswire 01.30.13 | 04:01 pm
- Auxilium Pharmaceuticals, Inc. And Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. For Infringement Of Testim® Patents - PR Newswire 01.28.13 | 05:01 pm
- Auxilium Pharmaceuticals, Inc. Announces Pricing Of $325.0 Million Of 1.50% Convertible Senior Notes Due 2018 - PR Newswire 01.25.13 | 07:01 am
- Auxilium Pharmaceuticals, Inc. Announces Offering Of Convertible Senior Notes Due 2018 - PR Newswire 01.23.13 | 04:01 pm
- Auxilium Pharmaceuticals, Inc. Announces Expansion Of Its Exclusive License For XIAFLEX® (CCH) To Include The Potential Treatment Of Cellulite As An Additional Indication - PR Newswire 01.07.13 | 07:01 am
- Auxilium Pharmaceuticals To Present At The J.P. Morgan 2013 Healthcare Conference - PR Newswire 01.03.13 | 07:01 am
Partner Headlines for AUXL
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 11.08.12 | 09:11 am
- Unusual Option Activity on Quad Witching - Benzinga 09.21.12 | 01:09 pm
- Neutral on Auxilium Pharma - Analyst Blog - NASDAQ 09.18.12 | 08:09 pm
- Update on Repros' Androxal - Analyst Blog - NASDAQ 09.14.12 | 09:09 pm
- Update on Repros' Androxal - Analyst Blog - Zacks 09.14.12 | 06:09 pm
- Auxilium Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 08.16.12 | 03:08 pm
- A Profitable Quarter for Auxilium - Analyst Blog - Zacks 08.02.12 | 09:08 am
- 2Q Revenues Decline at Actelion - Analyst Blog - Zacks 07.20.12 | 06:07 pm
- Canada Approves Auxilium's Xiaflex - Analyst Blog - Zacks 07.10.12 | 06:07 pm
- Canadian Stocks Mostly Lower in Defensive Session; Energy, Material Share Sliding - NASDAQ 07.09.12 | 06:07 pm
